Medpace Holdings (MEDP) Income from Continuing Operations (2015 - 2026)
Medpace Holdings (MEDP) reported Income from Continuing Operations of 123870000.0 for Q1 2026, up 8.09% on a YoY basis from 114595000.0 in Q1 2025, and down 8.33% quarter-over-quarter from 135133000.0 in Q4 2025.
Medpace Holdings (MEDP) Income from Continuing Operations (2015 - 2026) Analysis & Trends
Medpace Holdings has reported Income from Continuing Operations for 12 years, with the latest figure at 123870000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 8.09% year-over-year to 123870000.0; the trailing twelve-month figure through Mar 2026 stood at 460398000.0 (up 10.57% YoY), and the FY2025 full-year result was 451123000.0, up 11.56% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 123870000.0, down from 135133000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 135133000.0 in Q4 2025, with the low at 49360000.0 in Q2 2022.
- Historically, Income from Continuing Operations has averaged 88679823.53 across 5 years, with a median of 88351000.0 in 2024.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations surged 49.45% — and 2025, when it rose 2.16%.
- Medpace Holdings' Income from Continuing Operations stood at 68670000.0 in 2022, then climbed by 14.02% to 78298000.0 in 2023, then surged by 49.45% to 117018000.0 in 2024, then increased by 15.48% to 135133000.0 in 2025, then dropped by 8.33% to 123870000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 123870000.0 (Q1 2026), 135133000.0 (Q4 2025), and 111135000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 269.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | Medpace Holdings | 13.03 Bn | 12.38 Bn | 196.33 Mn | 123.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123.87 Mn |
| Dec 31, 2025 | 135.13 Mn |
| Sep 30, 2025 | 111.14 Mn |
| Jun 30, 2025 | 90.26 Mn |
| Mar 31, 2025 | 114.60 Mn |
| Dec 31, 2024 | 117.02 Mn |
| Sep 30, 2024 | 96.43 Mn |
| Jun 30, 2024 | 88.35 Mn |
| Mar 31, 2024 | 102.59 Mn |
| Dec 31, 2023 | 78.30 Mn |
| Sep 30, 2023 | 70.55 Mn |
| Jun 30, 2023 | 61.07 Mn |
| Mar 31, 2023 | 72.89 Mn |
| Dec 31, 2022 | 68.67 Mn |
| Sep 30, 2022 | 66.03 Mn |
| Jun 30, 2022 | 49.36 Mn |
| Mar 31, 2022 | 61.31 Mn |
| Dec 31, 2021 | 50.03 Mn |
| Sep 30, 2021 | 48.57 Mn |
| Jun 30, 2021 | 39.93 Mn |